Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatic Neoplasms | 10 | 2024 | 5349 | 0.740 |
Why?
|
N-Acetylgalactosaminyltransferases | 2 | 2018 | 63 | 0.690 |
Why?
|
Neoplastic Stem Cells | 6 | 2021 | 1347 | 0.560 |
Why?
|
Galactosyltransferases | 1 | 2018 | 276 | 0.550 |
Why?
|
Carcinoma, Pancreatic Ductal | 5 | 2024 | 1722 | 0.490 |
Why?
|
Mucins | 2 | 2015 | 568 | 0.490 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 611 | 0.360 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 1728 | 0.350 |
Why?
|
Glycosylation | 5 | 2021 | 1096 | 0.330 |
Why?
|
N-Acetylglucosaminyltransferases | 2 | 2020 | 167 | 0.300 |
Why?
|
Th17 Cells | 1 | 2013 | 787 | 0.280 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2803 | 0.240 |
Why?
|
Carcinoma, Renal Cell | 3 | 2024 | 3218 | 0.220 |
Why?
|
Leiomyomatosis | 1 | 2022 | 69 | 0.210 |
Why?
|
Kidney Neoplasms | 3 | 2024 | 4312 | 0.200 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6316 | 0.180 |
Why?
|
Retinal Dehydrogenase | 1 | 2020 | 78 | 0.180 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 2275 | 0.180 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 412 | 0.170 |
Why?
|
Glycosyltransferases | 1 | 2020 | 118 | 0.170 |
Why?
|
Cell Proliferation | 4 | 2018 | 10442 | 0.160 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2017 | 223 | 0.130 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 16932 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2024 | 8512 | 0.130 |
Why?
|
Gene Knockdown Techniques | 2 | 2018 | 1617 | 0.120 |
Why?
|
Neoplasms | 4 | 2018 | 22075 | 0.120 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4902 | 0.120 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1439 | 0.110 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2020 | 730 | 0.110 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2013 | 144 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2024 | 5251 | 0.100 |
Why?
|
CA-125 Antigen | 1 | 2014 | 279 | 0.100 |
Why?
|
Phosphorylation | 2 | 2020 | 8311 | 0.080 |
Why?
|
Polysaccharides | 1 | 2015 | 1016 | 0.080 |
Why?
|
Cell Movement | 2 | 2018 | 5206 | 0.070 |
Why?
|
Animals | 12 | 2024 | 167960 | 0.070 |
Why?
|
Neoplasm Transplantation | 2 | 2020 | 2014 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 1827 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13262 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2018 | 4938 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4319 | 0.060 |
Why?
|
Mice | 6 | 2024 | 81209 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22020 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2829 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1667 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2016 | 3539 | 0.050 |
Why?
|
Humans | 20 | 2024 | 760613 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2021 | 11481 | 0.050 |
Why?
|
Models, Biological | 2 | 2018 | 9468 | 0.050 |
Why?
|
Fumarate Hydratase | 1 | 2022 | 52 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5251 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11070 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5795 | 0.050 |
Why?
|
Disease Progression | 4 | 2021 | 13505 | 0.050 |
Why?
|
Signal Transduction | 4 | 2021 | 23374 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2012 | 3106 | 0.050 |
Why?
|
Lipids | 1 | 2012 | 3336 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4878 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3787 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7344 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 895 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7850 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2020 | 1342 | 0.030 |
Why?
|
Glycolysis | 1 | 2020 | 828 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2020 | 872 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2018 | 586 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1483 | 0.030 |
Why?
|
Prognosis | 3 | 2022 | 29661 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11152 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3016 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2005 | 0.020 |
Why?
|
Malondialdehyde | 1 | 2012 | 112 | 0.020 |
Why?
|
Pancreas | 1 | 2018 | 1677 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1628 | 0.020 |
Why?
|
Cell Membrane | 1 | 2020 | 3682 | 0.020 |
Why?
|
Glutathione Peroxidase | 1 | 2012 | 256 | 0.020 |
Why?
|
Female | 6 | 2024 | 391246 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 2924 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6130 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2012 | 594 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6900 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2012 | 641 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2013 | 58980 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9335 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9530 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2012 | 667 | 0.020 |
Why?
|
Middle Aged | 3 | 2024 | 220359 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12957 | 0.020 |
Why?
|
Male | 3 | 2024 | 359718 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21029 | 0.010 |
Why?
|
Triglycerides | 1 | 2012 | 2476 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2012 | 2141 | 0.010 |
Why?
|
Cholesterol | 1 | 2012 | 2924 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2014 | 3663 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18137 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16548 | 0.010 |
Why?
|
Aged | 1 | 2013 | 169143 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12810 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 29957 | 0.010 |
Why?
|
Transcription Factors | 1 | 2017 | 12102 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 64981 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 22052 | 0.010 |
Why?
|
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_